Zolmitriptan nasal spray (NS) was approved by the Food and Drug Administration in 2015 for acute migraine treatment in adolescents ages 12-17 years.
Oral
zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study.
Treatment Clinical trial [reference] options Acute medications
Zolmitriptan 2.
Ozkan, "Formulation of
zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation," European Journal of Pharmaceutics and Biopharmaceutics, vol.
Major Finding: The menstrual migraine recurrence rate 48 hours after treatment with frovatriptan was 15%, significantly less than the collective 26% rate after treatment with rizatriptan,
zolmitriptan, or almotriptan.
gununde bas agrisi ve cift gorme sikayetlerinin azalmasi sonucunda azalan dozlarla oral prednol 0,4 mg/kg (Prednol tablet 16 mg 1x1 0,4 mg/kg) ve
Zolmitriptan (Zomig tablet 2,5 mg 1x1) onerilerek taburcu edildi.
Oksijen inhalasyonu, sumatriptan, dihidroergotamin,
zolmitriptan ve lokal anestetikler suratli ve etkin atak kontrolu saglarlar.
Medications that treat migraines: Anti inflammatories Aspirin (Bayer, Bufferin, Excedrin), ibuprofen (Motrin, Advil), naproxen (Aleve, Nuprin) Triptans Sumatriptan (Imitrex), rizatriptan (Maxalt),
zolmitriptan (Zomig) Ergotamines DHE (dihydroergotamine) nasal spray (Migranal), DHE injection.
sumatriptan,
zolmitriptan, eletriptan) may also lead to serotonin excess, and should be avoided.
In the 6-month follow-up period after the 9-week intervention period, 26 veterans received additional medications for their headaches, usually choline magnesium trisalisylate or another nonsteroidal anti-inflammatory medication to treat tension-like components of headache pain;
zolmitriptan to abort migraine headaches; and an agent such as topirimate, metoprolol, tricyclic antidepressant medication, or divalproex sodium to prevent headaches.
Patients treated three attacks, at least 24 hours apart, with 5 mg or 10 mg of
zolmitriptan nasal spray or placebo, without realizing which treatment they were using.
In a randomised study of 1,380 people with moderate or severe migraine telcagepant was as effective as
zolmitriptan, the most commonly used triptan, and was associated with fewer adverse effects, Dr Tony Ho of Merck Research Laboratories in Philadelphia said in the report.
